| Dr Daniel V Zimmer, MD | |
|
105 Brandt Dr., Suite 201, Cranberry Twp., PA 16066-6412 | |
| (724) 772-5420 | |
| (724) 772-5423 |
| Full Name | Dr Daniel V Zimmer |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 105 Brandt Dr., Cranberry Twp., Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265438634 | NPI | - | NPPES |
| 0000740507 | Other | PA | AMERIHEALTH ADMINISTRATOR |
| 000000092591 | Other | PA | UNISON HEALTH PLAN |
| 103105 | Other | PA | UPMC HEALTH PLAN |
| 0015779570007 | Medicaid | PA | |
| 28628 | Other | PA | ADVANTRA/ HEALTH AMERICA |
| ZI740507 | Other | PA | UMWA |
| 740507 | Other | PA | HIGHMARK BCBS |
| 1513104 | Other | PA | GATEWAY HEALTH PLAN |
| 180017416 | Other | PA | RAILROAD MEDICARE |
| 450883 | Other | PA | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD050044L (Pennsylvania) | Primary |
| Entity Name | Scott & Christie And Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386635159 PECOS PAC ID: 3476534264 Enrollment ID: O20040527000370 |
News Archive
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Prostate cancer is the most common type of cancer among men, but its diagnosis has up to now been inaccurate and unpleasant. Researchers at Eindhoven University of Technology in the Netherlands, in cooperation with AMC Amsterdam, have developed an imaging technology that can accurately identify tumors.
The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation solution through lungs that were initially thought to be unacceptable for transplant.
At the Keystone Symposium "New Frontiers in Neurodegenerative Disease Research," held 4-7 February in Santa Fe, New Mexico, researchers explored the processes that lead to a variety of diseases, including Alzheimer's and Lou Gehrig's disease (amyotrophic lateral sclerosis, ALS).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel V Zimmer, MD 105 Brandt Dr., Suite 201, Cranberry Twp., PA 16066-6412 Ph: (724) 772-5420 | Dr Daniel V Zimmer, MD 105 Brandt Dr., Suite 201, Cranberry Twp., PA 16066-6412 Ph: (724) 772-5420 |
News Archive
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Prostate cancer is the most common type of cancer among men, but its diagnosis has up to now been inaccurate and unpleasant. Researchers at Eindhoven University of Technology in the Netherlands, in cooperation with AMC Amsterdam, have developed an imaging technology that can accurately identify tumors.
The U.S. Food and Drug Administration today approved a device, called Xvivo Perfusion System with Steen Solution Perfusate, that can temporarily ventilate, oxygenate, and pump (perfuse) preservation solution through lungs that were initially thought to be unacceptable for transplant.
At the Keystone Symposium "New Frontiers in Neurodegenerative Disease Research," held 4-7 February in Santa Fe, New Mexico, researchers explored the processes that lead to a variety of diseases, including Alzheimer's and Lou Gehrig's disease (amyotrophic lateral sclerosis, ALS).
› Verified 9 days ago